Krishnan Nandabalan Insider Profile
4 Followers
Krishnan Nandabalan, Director, Ten Percent Owner at Bioxcel Therapeutics, holds 8.55M shares in Bioxcel Therapeutics (Ticker: BTAIQ).
Krishnan Nandabalan's Trading History
| BTAIQBioxcel Therapeutics | Apr 10, 2023 | Director, Ten Percent Owner | Uninformative Buy | 24.60K | $94.01K | |
BTAIQ Insider Shares: 8.55M (29.46%) | ||||||
You May Also Like
Krishnan Nandabalan insider profile FAQ
What is the percentage of profitable transactions made by Krishnan Nandabalan?
The percentage of profitable transactions made by Krishnan Nandabalan is 100%.
What is the average return per transaction made by Krishnan Nandabalan?
The average return per transaction made by Krishnan Nandabalan is 42.50%.
What stocks does Krishnan Nandabalan hold?
Krishnan Nandabalan holds: BTAIQ stocks.
What was Krishnan Nandabalan’s latest transaction?
Krishnan Nandabalan’s latest transaction was an Uninformative Buy of $24.60K.
What was Krishnan Nandabalan's most profitable transaction?
Krishnan Nandabalan’s most profitable transaction was an Informative Sell of BTAIQ stock on June 29, 2021. The return on the trade was 56.30%.
What is Krishnan Nandabalan's role in Bioxcel Therapeutics?
Krishnan Nandabalan's role in Bioxcel Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
